These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 27866195

  • 21. Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial.
    An J, Lim YS, Kim GA, Han SB, Jeong W, Lee D, Shim JH, Lee HC, Lee YS.
    BMC Gastroenterol; 2017 Jan 19; 17(1):15. PubMed ID: 28103819
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance.
    Wang G, Liu Y, Qiu P, Zhou SF, Xu L, Wen P, Wen J, Xiao X.
    Drug Des Devel Ther; 2015 Jan 19; 9():2839-46. PubMed ID: 26082614
    [Abstract] [Full Text] [Related]

  • 23. Comparison of 208-week sequential therapy with telbivudine and entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg-IFNα-2a therapy: An open-labelled, randomized, controlled, "real-life" trial.
    Luo XD, Chen XF, Zhou Y, Chen XP.
    J Viral Hepat; 2017 Nov 19; 24 Suppl 1():36-42. PubMed ID: 29082651
    [Abstract] [Full Text] [Related]

  • 24. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
    Tsai MC, Chen CH, Tseng PL, Hung CH, Chiu KW, Wang JH, Lu SN, Lee CM, Chang KC, Yen YH, Lin MT, Chou YP, Hu TH.
    Clin Microbiol Infect; 2016 Jan 19; 22(1):95.e1-95.e7. PubMed ID: 26055419
    [Abstract] [Full Text] [Related]

  • 25. A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.
    Lin KH, Chen YL, Lin PY, Hsieh CE, Ko CJ, Lin CC, Ming YZ.
    Exp Clin Transplant; 2017 Feb 19; 15(1):65-68. PubMed ID: 28004999
    [Abstract] [Full Text] [Related]

  • 26. [Influence of monotherapy with telbivudine or entecavir on renal function in patients with chronic hepatitis B].
    Li W, Zhang D.
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jun 19; 23(6):407-11. PubMed ID: 26236924
    [Abstract] [Full Text] [Related]

  • 27. Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis.
    Han Z, Shi Y, Zhu J, Chen Y, Yin F, Xia L, Luo G, Gao Z, Liu J, Jia G, Li C, Zhou X, Han Y.
    J Viral Hepat; 2013 Apr 19; 20 Suppl 1():58-64. PubMed ID: 23458526
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients.
    Durante-Mangoni E, Vitrone M, Parrella A, Andini R, Iossa D, Ragone E, Falco E, Maiello C, Utili R, Zampino R.
    Transpl Infect Dis; 2016 Jun 19; 18(3):319-25. PubMed ID: 26988401
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of three adefovir-based combination therapies in HBeAg-positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy.
    Wang ML, Chen EQ, Zhang DM, Du LY, Yan LB, Zhou TY, Lei XZ, Lei BJ, Lu JJ, Liao J, Tang H.
    J Viral Hepat; 2017 Nov 19; 24 Suppl 1():21-28. PubMed ID: 29082645
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.
    Guo X, Wu J, Wei F, Ouyang Y, Li Q, Liu K, Wang Y, Zhang Y, Chen D.
    Int J Antimicrob Agents; 2018 Aug 19; 52(2):201-209. PubMed ID: 29654894
    [Abstract] [Full Text] [Related]

  • 32. Telbivudine improves renal function in patients with chronic hepatitis B.
    Gane EJ, Deray G, Liaw YF, Lim SG, Lai CL, Rasenack J, Wang Y, Papatheodoridis G, Di Bisceglie A, Buti M, Samuel D, Uddin A, Bosset S, Trylesinski A.
    Gastroenterology; 2014 Jan 19; 146(1):138-146.e5. PubMed ID: 24067879
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.
    Kara AV, Yıldırım Y, Ozcicek F, Aldemir MN, Arslan Y, Bayan K, Çelen MK.
    Acta Gastroenterol Belg; 2019 Jan 19; 82(2):273-277. PubMed ID: 31314188
    [Abstract] [Full Text] [Related]

  • 35. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S, Gao S, Zhao M, Liu Y, Bu Y, Jiang Q, Zhao Q, Ye L, Zhang X.
    Cancer Lett; 2017 Apr 28; 392():94-104. PubMed ID: 28192212
    [Abstract] [Full Text] [Related]

  • 36. A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China.
    Zhang Y, Hu P, Qi X, Ren H, Mao RC, Zhang JM.
    Clin Microbiol Infect; 2016 Mar 28; 22(3):287.e1-9. PubMed ID: 26548508
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
    Wang JL, Du XF, Chen SL, Yu YQ, Wang J, Hu XQ, Shao LY, Chen JZ, Weng XH, Zhang WH.
    World J Gastroenterol; 2015 Aug 28; 21(32):9598-606. PubMed ID: 26327767
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.
    Shim JH, Lee HC, Kim KM, Lim YS, Chung YH, Lee YS, Suh DJ.
    J Hepatol; 2010 Feb 28; 52(2):176-82. PubMed ID: 20006394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.